Our Team.

Phoebe manages our drug portfolio, collaborates with cross-functional teams to prioritize and advance repurposing candidates, and builds strategic partnerships to integrate these therapies into the standard of care. Previously, Phoebe served as Director of Business Development at Fortress Biotech, where she engaged with the rare disease community to evaluate and advance drug repurposing efforts. She also worked as an Engagement Manager at Prescient Healthcare Group, leading competitive intelligence projects and managing teams to deliver strategic insights for global pharmaceutical clients. Phoebe earned a PhD in Molecular Genetics and Microbiology from Duke University and an MBA from Villanova University, and she was an intramural postdoctoral researcher at the National Cancer Institute.